Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-07
DOI
10.1186/s12964-020-0519-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer
- (2019) Jieun Park et al. Scientific Reports
- A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS
- (2019) Won-Ji Ryu et al. Cancers
- WDR76 degrades RAS and suppresses cancer stem cell activation in colorectal cancer
- (2019) Eun Ji Ro et al. Cell Communication and Signaling
- β‐Catenin‐RAS interaction serves as a molecular switch for RAS degradation via GSK3β
- (2018) Sang‐Kyu Lee et al. EMBO REPORTS
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- (2018) Adriana Sánchez-Danés et al. NATURE
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
- (2017) Felipe de Sousa e Melo et al. NATURE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors
- (2016) Hye-Young Min et al. CLINICAL CANCER RESEARCH
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation
- (2016) Pu-Hyeon Cha et al. Nature Chemical Biology
- Patterns of metastasis in colon and rectal cancer
- (2016) Matias Riihimäki et al. Scientific Reports
- CD44 functions in Wnt signaling by regulating LRP6 localization and activation
- (2014) M Schmitt et al. CELL DEATH AND DIFFERENTIATION
- Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling
- (2014) Byoung-San Moon et al. JNCI-Journal of the National Cancer Institute
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- RAS signaling pathways, mutations and their role in colorectal cancer
- (2013) Kypros Zenonos World Journal of Gastrointestinal Oncology
- Wnt/ -Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields
- (2012) D. Guardavaccaro et al. Science Signaling
- Ras Stabilization Through Aberrant Activation of Wnt/ -Catenin Signaling Promotes Intestinal Tumorigenesis
- (2012) W.-J. Jeong et al. Science Signaling
- Mutant Kras Promotes Hyperplasia and Alters Differentiation in the Colon Epithelium but Does Not Expand the Presumptive Stem Cell Pool
- (2011) Ying Feng et al. GASTROENTEROLOGY
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation